PharmiWeb.com - Global Pharma News & Resources
17-Jun-2019

Genetic Testing Market Size is Anticipated to Surpass USD 18 Billion up to 2026

Global Genetic Testing Market Size is expected to reach USD 18 Billion by 2026 and growing CAGR around 11 % during the forecast period.

The global Genetic Testing Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2019 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2019 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1351

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Genetic Testing Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Genetic Testing Market market?
  • What is the market drivers, restrains, opportunities governing the global Genetic Testing Market Market?
  • Which is the largest and the fastest growing segments in the global Genetic Testing Market market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1351

Market Players:

23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularMD, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostic is among the most eminent players in the global genetic testing market. Industry players focus on the strategic expansion of their product portfolio through acquisitions, fusions and collaborations. Roche, for example, in December 2018, acquired the Non-invasive Prenatal (NIPT) and cell-free DNA testing services market Ariosa Diagnostics, a provider of molecular diagnostic testing services.

The Major Market Segments of GlobalGenetic Testing Marketare as below:

Market Segmentation

Market, by Type

  • Predictive Testing
  • Prenatal amp; Newborn Testing
  • Diagnostic Testing
  • Carrier Testing
  • Pharmacogenomic Testing
  • Others

Market, by Technology

  • Biochemical Testing
  • Cytogenetic Testing/ Chromosome Analysis
  • Molecular Testing
    • DNA Sequencing
    • Others

Market, by Application

  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Chromosome Analysis
  • Others

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on Genetic Testing Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026offers detailed insights on global Genetic Testing market segments with market dynamics and their impact. The report also covers basic technology development policies.

The global market for genetic testing is driven by a range of factors, such as progress in genetic testing, an ever greater prevalence of genetic diseases and an increase in awareness. In addition, the market for genetic testing was driven by government initiatives and increased Ramp;D activity in the field. However, the world market in genetic testing is restricted by high costs, the lack of skilled professionals and stringent regulations in some regions.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Genetic Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Genetic Testing Market By Type
1.2.2.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Genetic Testing Market Revenue Share By Type in 2017
1.2.2.3. Predictive Testing
1.2.2.4. Prenatal amp; Newborn Testing
1.2.2.5. Diagnostic Testing
1.2.2.6. Carrier Testing
1.2.2.7. Pharmacogenomic Testing
1.2.2.8. Others
1.2.3. Genetic Testing Market By Technology
1.2.3.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Genetic Testing Market Revenue Share By Technology in 2017
1.2.3.3. Biochemical Testing
1.2.3.4. Cytogenetic Testing/ Chromosome Analysis
1.2.3.5. Molecular Testing
1.2.3.6. DNA Sequencing
1.2.3.7. Others
1.2.4. Genetic Testing Market By Application
1.2.4.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Genetic Testing Market Revenue Share By Application in 2017
1.2.4.3. Genetic Disease Diagnosis
1.2.4.4. Cardiovascular Disease Diagnosis
1.2.4.5. Chromosome Analysis
1.2.4.6. Others
1.2.5. Genetic Testing Market by Geography
1.2.5.1. Global Genetic Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Genetic Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Genetic Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Genetic Testing Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Genetic Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Genetic Testing Major Manufacturers in 2017

CHAPTER 4. GENETIC TESTING MARKET BY TYPE

4.1. Global Genetic Testing Revenue By Type
4.2. Predictive Testing
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Prenatal amp; Newborn Testing
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Diagnostic Testing
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Carrier Testing
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Pharmacogenomic Testing
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. GENETIC TESTING MARKET BY TECHNOLOGY

5.1. Global Genetic Testing Revenue By Technology
5.2. Biochemical Testing
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cytogenetic Testing/ Chromosome Analysis
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Molecular Testing
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. DNA Sequencing
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. GENETIC TESTING MARKET BY APPLICATION

6.1. Global Genetic Testing Revenue By Application
6.2. Genetic Disease Diagnosis
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Cardiovascular Disease Diagnosis
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Chromosome Analysis
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY

7.1. North America Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Genetic Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Genetic Testing Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE GENETIC TESTING MARKET BY COUNTRY

8.1. Europe Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Genetic Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC GENETIC TESTING MARKET BY COUNTRY

9.1. Asia-Pacific Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Genetic Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA GENETIC TESTING MARKET BY COUNTRY

10.1. Latin America Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Genetic Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST GENETIC TESTING MARKET BY COUNTRY

11.1. Middle East Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Genetic Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA GENETIC TESTING MARKET BY COUNTRY

12.1. Africa Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Genetic Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. 23andMe
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abbott Molecular
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Biocartis
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. BioHelix
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bayer Diagnostics
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. BioMerieux
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. BGI
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Celera Genomics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Cepheid
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Counsyl
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. deCODEme
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Product Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Genentech
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Product Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Genomictree
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Product Portfolio
13.13.5. Key Developments
13.13.6. Strategies
13.14. HTG Molecular Diagnostics
13.14.1. Company Snapshot
13.14.2. Overview
13.14.3. Financial Overview
13.14.4. Product Portfolio
13.14.5. Key Developments
13.14.6. Strategies
13.15. Luminex
13.15.1. Company Snapshot
13.15.2. Overview
13.15.3. Financial Overview
13.15.4. Product Portfolio
13.15.5. Key Developments
13.15.6. Strategies
13.16. MolecularMD
13.16.1. Company Snapshot
13.16.2. Overview
13.16.3. Financial Overview
13.16.4. Product Portfolio
13.16.5. Key Developments
13.16.6. Strategies
13.17. IntegraGen
13.17.1. Company Snapshot
13.17.2. Overview
13.17.3. Financial Overview
13.17.4. Product Portfolio
13.17.5. Key Developments
13.17.6. Strategies
13.18. LabCorp diagnostics
13.18.1. Company Snapshot
13.18.2. Overview
13.18.3. Financial Overview
13.18.4. Product Portfolio
13.18.5. Key Developments
13.18.6. Strategies
13.19. Myriad
13.19.1. Company Snapshot
13.19.2. Overview
13.19.3. Financial Overview
13.19.4. Product Portfolio
13.19.5. Key Developments
13.19.6. Strategies
13.20. Natera
13.20.1. Company Snapshot
13.20.2. Overview
13.20.3. Financial Overview
13.20.4. Product Portfolio
13.20.5. Key Developments
13.20.6. Strategies
13.21. PacBio
13.21.1. Company Snapshot
13.21.2. Overview
13.21.3. Financial Overview
13.21.4. Product Portfolio
13.21.5. Key Developments
13.21.6. Strategies
13.22. Pathway Genomics
13.22.1. Company Snapshot
13.22.2. Overview
13.22.3. Financial Overview
13.22.4. Product Portfolio
13.22.5. Key Developments
13.22.6. Strategies
13.23. Qiagen
13.23.1. Company Snapshot
13.23.2. Overview
13.23.3. Financial Overview
13.23.4. Product Portfolio
13.23.5. Key Developments
13.23.6. Strategies
13.24. Roche Diagnostic
13.24.1. Company Snapshot
13.24.2. Overview
13.24.3. Financial Overview
13.24.4. Product Portfolio
13.24.5. Key Developments
13.24.6. Strategies
13.25. Others
13.25.1. Company Snapshot
13.25.2. Overview
13.25.3. Financial Overview
13.25.4. Product Portfolio
13.25.5. Key Developments
13.25.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1351

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 17-Jun-2019